BridgeMD
Tests treatment safety and results for Cancer
Official title A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemotherapy
ClinicalTrials.gov ID: NCT06706752
What this study is testing
- What it's testing
- The goal of this clinical trial is to assess whether Shengbai Oral Formula is a viable option for treatment of fatigue, pain, and neutropenia in patients undergoing their third cycle of chemotherapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- 18-80 years of age
- A cancer diagnosis and scheduled to undergo at least three rounds of chemotherapy for curative or palliative intent
- Chemotherapy is given at a minimum of every 2 weeks
- At least 30 days past radiation therapy
- Nonpregnant and use of method of contraception per the treating clinician standard of care
You likely can't join if
- Abnormal ALT/AST: \> 2.5 to 3 times normal range
- eGFR \<60
- Platelets \< 75,000
- Hb \<8.0
- ANC \<1000
- Documentation of a bone marrow transplant
See the full eligibility criteria
- 18-80 years of age
- A cancer diagnosis and scheduled to undergo at least three rounds of chemotherapy for curative or palliative intent
- Chemotherapy is given at a minimum of every 2 weeks
- At least 30 days past radiation therapy
- Nonpregnant and use of method of contraception per the treating clinician standard of care
- Life expectancy \> 3 months
- Stable on all herbal or complementary therapeutics for the past 30 days and agree to not include new complementary therapeutics until after study completion
- Baseline ECOG ≤ 2
- In the opinion of the investigator, the subject will be compliant and have a high probability of completing the study including all scheduled evaluations and required tests
- Abnormal ALT/AST: \> 2.5 to 3 times normal range
- eGFR \<60
- Platelets \< 75,000
- Hb \<8.0
- ANC \<1000
- Documentation of a bone marrow transplant
- Documentation of brain metastases, diagnosis with other cancer, except skin cancer history with basal cell carcinoma, squamous carcinoma
- Documentation of current seizure disorder
- Documentation of new cardiac arrhythmias and myocardial infarction
- Any active bacterial or viral infection, pneumonia, sepsis, active gastric ulcer, gastritis, nonhealing wound, intractable nausea or vomiting, diarrhea, bleeding disorder
- Hyperthyroidism, connective tissue disease including systemic lupus erythematous, rheumatoid arthritis
- Documentation of a current drug abuse disorder
- Current participation in other clinical trial
The study team makes the final eligibility decision.
Where it's taking place
- Oakland, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oakland, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.